{
    "nctId": "NCT02504424",
    "briefTitle": "AirXpanders AeroForm Tissue Expander System for Breast Reconstruction",
    "officialTitle": "AirXpanders AeroForm Tissue Expander System for Breast Reconstruction (XPAND-II)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Number of Breasts With Successful Tissue Expansion With Exchange to a Permanent Breast Implant Unless Exchange is Precluded by a Non-device Related Event",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Subject is female between the ages of 18-70\n* Subject requires tissue expansion as part of breast reconstruction\n* Subject is able to provide written informed consent\n* Subject is able and willing to comply with all of the study requirements\n* Subject has the physical, perceptual and cognitive capacity to understand and manage the at home dosing regimen\n\nExclusion Criteria:\n\n* Subject's tissue integrity is unsuitable for tissue expansion\n* Subject has residual gross malignancy at the intended expansion site\n* Subject has current or prior infection at the intended expansion site\n* Subject has a history of failed tissue expansion or breast reconstruction\n* Subject has any co-morbid condition determined by the Investigator to place the subject at an increased risk of complications (e.g., severe collagen vascular disease, poorly managed diabetes)\n* Subject is taking any concomitant medications determined by the Investigator to place the subject at an increased risk of complications (e.g., Prednisone, Coumadin).",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}